Ocular herpes simplex infection: pathogenesis and current therapy.
Ocular herpes simplex disease has a variable pattern of manifestations and recurrences as a result of the site and extent of the infection, the host immunologic events, the trophic damage within ocular tissues, and the toxic effects of antiviral medications. Laboratory research has established a clinical model and a working hypothesis about the complex pathophysiologic features of the disease and the interaction of the virus with its host tissue. Recent studies have further defined the viral genome and its role in virulence and pathogenicity. Antiviral therapy is effective in some but not all aspects of the ocular infection. A proposed clinical classification of ocular herpes simplex is based on the manifestations associated with viral disease and those associated with the host response and the subsequent structural damage. A plan for medical and surgical management of ocular herpes simplex, based on current knowledge of the disease process, relates to the integrity of the epithelium and the presence of active viral disease.
Liesegang
T J
TJ
Department of Ophthalmology, Mayo Clinic Jacksonville, FL 32224.
D006801:Humans; D007635:Keratitis, Dendritic / Q000145:classification / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D012008:Recurrence; D018139:Simplexvirus / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000627:therapeutic use
D014765:Viral Vaccines